"Strategies for vaccines for the 21st century" with Prof Susan Lea, Prof Christoph Tang, Prof Jeffrey Almond & Dr Ian Feavers

09 December 2014

Portrait of Professor Susan Lea

with Professor Susan Lea
Statutory Chair of Microbiology

Oxford Martin Senior Alumni FellowProfessor Susan Lea was a Co-Director of the Oxford Martin Programme on Vaccines from 2010-2015.Susan is primarily interested in what structural biology can help us understand about the way in which pathogens and the...

Portrait of Professor Christoph Tang

with Professor Christoph Tang
Glaxo Professor of Cellular Pathology

Oxford Martin Senior Alumni FellowChristoph Tang is Professor of Cellular Pathology at the Sir William Dunn School of Pathology, Professorial Fellow at Exeter College and a Wellcome Trust Senior Investigator. he was awarded a PhD at the Royal Postgra...

Vaccines have saved an estimated 500 million lives around the world since Edward Jenner discovered how to prevent smallpox infection in 1796. But a successful vaccine roll-out is about more than just medicine; it encompasses engineering, economics, policy, government and even transport infrastructure. More than a decade into the 21st century, and with a new outbreak of the Ebola virus claiming thousands of lives in Africa, does a successful strategy for creating and delivering new vaccines require a whole new approach?